These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 25114322)
1. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report. van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322 [TBL] [Abstract][Full Text] [Related]
2. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Unemo M; Golparian D; Potočnik M; Jeverica S Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003 [TBL] [Abstract][Full Text] [Related]
3. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533 [TBL] [Abstract][Full Text] [Related]
4. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Tapsall JW Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600 [TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related]
6. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection. Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431 [TBL] [Abstract][Full Text] [Related]
7. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime. Korting HC; Abeck D Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957 [TBL] [Abstract][Full Text] [Related]
9. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea]. Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358 [TBL] [Abstract][Full Text] [Related]
10. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Unemo M; Golparian D; Syversen G; Vestrheim DF; Moi H Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144442 [TBL] [Abstract][Full Text] [Related]
11. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634 [TBL] [Abstract][Full Text] [Related]
12. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae? Rice LB Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405 [No Abstract] [Full Text] [Related]
13. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Ison CA; Hussey J; Sankar KN; Evans J; Alexander S Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528 [TBL] [Abstract][Full Text] [Related]
14. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae. Golden MR; Barbee LA; Kerani R; Dombrowski JC Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259 [TBL] [Abstract][Full Text] [Related]
15. [Ceftriaxone as a single-dose treatment for male gonococcal urethritis]. Urabe S; Shigematsu S Jpn J Antibiot; 1984 Nov; 37(11):2169-73. PubMed ID: 6098709 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea. Unemo M; Golparian D; Oxelbark J; Kong FYS; Brown D; Louie A; Drusano G; Jacobsson S J Antimicrob Chemother; 2024 May; 79(5):1006-1013. PubMed ID: 38497988 [TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands. de Vries HJ; van der Helm JJ; Schim van der Loeff MF; van Dam AP Euro Surveill; 2009 Sep; 14(37):. PubMed ID: 19761737 [TBL] [Abstract][Full Text] [Related]
18. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study. van Amerongen R; Gazendam RP; van Bergen JEAM BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849 [TBL] [Abstract][Full Text] [Related]
19. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea. Mogabgab WJ; Lutz FB South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771 [TBL] [Abstract][Full Text] [Related]
20. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Unemo M; Golparian D; Stary A; Eigentler A Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]